Petmed Express Stock Current Valuation
| PETS Stock | USD 4.42 0.12 2.79% |
Valuation analysis of PetMed Express helps investors to measure PetMed Express' intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns. Enterprise Value Over EBITDA is likely to gain to -32.17 in 2025. Enterprise Value Multiple is likely to gain to -32.17 in 2025. Fundamental drivers impacting PetMed Express' valuation include:
Overvalued
Today
Please note that PetMed Express' price fluctuation is risky at this time. Calculation of the real value of PetMed Express is based on 3 months time horizon. Increasing PetMed Express' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the PetMed stock is determined by what a typical buyer is willing to pay for full or partial control of PetMed Express. Since PetMed Express is currently traded on the exchange, buyers and sellers on that exchange determine the market value of PetMed Stock. However, PetMed Express' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 4.42 | Real 3.98 | Target 3.75 | Hype 4.43 | Naive 4.85 |
The intrinsic value of PetMed Express' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence PetMed Express' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of PetMed Express helps investors to forecast how PetMed stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of PetMed Express more accurately as focusing exclusively on PetMed Express' fundamentals will not take into account other important factors: PetMed Express Company Current Valuation Analysis
PetMed Express' Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current PetMed Express Current Valuation | 39.84 M |
Most of PetMed Express' fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, PetMed Express is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
PetMed Current Valuation Driver Correlations
Understanding the fundamental principles of building solid financial models for PetMed Express is extremely important. It helps to project a fair market value of PetMed Stock properly, considering its historical fundamentals such as Current Valuation. Since PetMed Express' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of PetMed Express' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of PetMed Express' interrelated accounts and indicators.
Click cells to compare fundamentals
PetMed Current Valuation Historical Pattern
Today, most investors in PetMed Express Stock are looking for potential investment opportunities by analyzing not only static indicators but also various PetMed Express' growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's current valuation growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of PetMed Express current valuation as a starting point in their analysis.
PetMed Express Current Valuation |
| Timeline |
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, PetMed Express has a Current Valuation of 39.84 M. This is 99.72% lower than that of the Specialty Retail sector and significantly higher than that of the Consumer Discretionary industry. The current valuation for all United States stocks is 99.76% higher than that of the company.
PetMed Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses PetMed Express' direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of PetMed Express could also be used in its relative valuation, which is a method of valuing PetMed Express by comparing valuation metrics of similar companies.PetMed Express is currently under evaluation in current valuation category among its peers.
PetMed Express ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, PetMed Express' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to PetMed Express' managers, analysts, and investors.Environmental | Governance | Social |
PetMed Fundamentals
| Return On Equity | 0.0036 | ||||
| Return On Asset | 0.0093 | ||||
| Profit Margin | 0 % | ||||
| Operating Margin | (0.01) % | ||||
| Current Valuation | 39.84 M | ||||
| Shares Outstanding | 20.66 M | ||||
| Shares Owned By Insiders | 16.81 % | ||||
| Shares Owned By Institutions | 45.29 % | ||||
| Number Of Shares Shorted | 1.5 M | ||||
| Price To Earning | 12.75 X | ||||
| Price To Book | 0.92 X | ||||
| Price To Sales | 0.37 X | ||||
| Revenue | 281.06 M | ||||
| Gross Profit | 68.37 M | ||||
| EBITDA | (1.11 M) | ||||
| Net Income | (7.46 M) | ||||
| Cash And Equivalents | 105.41 M | ||||
| Cash Per Share | 5.21 X | ||||
| Total Debt | 1.45 M | ||||
| Current Ratio | 5.61 X | ||||
| Book Value Per Share | 4.66 X | ||||
| Cash Flow From Operations | 4.32 M | ||||
| Short Ratio | 4.81 X | ||||
| Earnings Per Share | 0.01 X | ||||
| Price To Earnings To Growth | 2.58 X | ||||
| Target Price | 3.75 | ||||
| Number Of Employees | 287 | ||||
| Beta | 0.7 | ||||
| Market Capitalization | 91.3 M | ||||
| Total Asset | 169.88 M | ||||
| Retained Earnings | 71.56 M | ||||
| Working Capital | 21.49 M | ||||
| Current Asset | 67.63 M | ||||
| Current Liabilities | 7.08 M | ||||
| Five Year Return | 3.99 % | ||||
| Net Asset | 169.88 M | ||||
| Last Dividend Paid | 0.3 |
About PetMed Express Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze PetMed Express's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of PetMed Express using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of PetMed Express based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for PetMed Stock Analysis
When running PetMed Express' price analysis, check to measure PetMed Express' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy PetMed Express is operating at the current time. Most of PetMed Express' value examination focuses on studying past and present price action to predict the probability of PetMed Express' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move PetMed Express' price. Additionally, you may evaluate how the addition of PetMed Express to your portfolios can decrease your overall portfolio volatility.